The Role of Confocal Microscopy in Estimating Dupilumab Treatment Response for Moderate/Severe Atopic Dermatitis
Active, not recruitingOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
April 24, 2024
Primary Completion Date
December 12, 2025
Study Completion Date
April 12, 2026
Conditions
Atopic Dermatitis
Trial Locations (1)
1199
Hospital Italiano de Buenos Aires, Buenos Aires
All Listed Sponsors
lead
Hospital Italiano de Buenos Aires
OTHER
NCT07098000 - The Role of Confocal Microscopy in Estimating Dupilumab Treatment Response for Moderate/Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter